Literature DB >> 9220162

Perioperative variation in phagocytic activity against Candida albicans measured by a flow-cytometric assay in cardiovascular-surgery patients.

T L Tran1, P Auger, A R Marchand, M Carrier, C Pelletier.   

Abstract

Candidiasis is an opportunistic fungal infection that frequently occurs following modifications of host defenses. Major surgery can be responsible for such alterations, and therefore it increases the risk of fungal infection. The purpose of this study was to evaluate the perioperative impairment of leukocyte function in patients after cardiovascular surgery by measuring the phagocytic activity against Candida albicans by a flow-cytometric method. The average postsurgical decrease in phagocytosis in our patients was 11.4%. By univariate analysis, three factors, all related to antibiotic therapy, were significantly associated with an important decrease in phagocytosis; the use of antimicrobial therapy before surgery, the number of different antibiotics taken, and the length of antibiotic treatment. The results of our study showed that the use of antibiotics in patients undergoing cardiovascular surgery alters the normal phagocytic activity of the host immune system against C. albicans and that flow cytometry is a rapid and simple technique that helps in early identification of patients at high risk for Candida infections. The mechanisms by which surgery and antibiotics decrease phagocytosis remain to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9220162      PMCID: PMC170548          DOI: 10.1128/cdli.4.4.447-451.1997

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  18 in total

1.  Effect of antimicrobial and antineoplastic drugs alone and in combination on the phagocytic and candidacidal function of human polymorphonuclear leucocytes.

Authors:  C J Pallister; D W Warnock
Journal:  J Antimicrob Chemother       Date:  1989-01       Impact factor: 5.790

2.  Protein-calorie malnutrition impairs host defense against Candida albicans.

Authors:  H P Redmond; J Shou; C J Kelly; P Leon; J M Daly
Journal:  J Surg Res       Date:  1991-06       Impact factor: 2.192

3.  Activity of vancomycin and teicoplanin against human polymorphonuclear leucocytes: a comparative study.

Authors:  F J Morán; L F Puente; C Pérez-Giraldo; M T Blanco; C Hurtado; A C Gómez-García
Journal:  J Antimicrob Chemother       Date:  1991-09       Impact factor: 5.790

Review 4.  Early diagnosis of systemic candidal infection.

Authors:  R C Matthews
Journal:  J Antimicrob Chemother       Date:  1993-06       Impact factor: 5.790

Review 5.  Current strategies for treating invasive candidiasis: emphasis on infections in nonneutropenic patients.

Authors:  J E Edwards; S G Filler
Journal:  Clin Infect Dis       Date:  1992-03       Impact factor: 9.079

6.  Risk factors for hospital-acquired candidemia. A matched case-control study.

Authors:  S B Wey; M Mori; M A Pfaller; R F Woolson; R P Wenzel
Journal:  Arch Intern Med       Date:  1989-10

7.  Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.

Authors:  C Beck-Sagué; W R Jarvis
Journal:  J Infect Dis       Date:  1993-05       Impact factor: 5.226

8.  Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System.

Authors:  S N Banerjee; T G Emori; D H Culver; R P Gaynes; W R Jarvis; T Horan; J R Edwards; J Tolson; T Henderson; W J Martone
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

9.  Quantitative analysis of opsonophagocytosis and of killing of Candida albicans by human peripheral blood leukocytes by using flow cytometry.

Authors:  E Martin; S Bhakdi
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

10.  [Use of flow cytometry in the study of a non-specific immunodeficiency in children. A case].

Authors:  H Rabesandratana; F Jouanneau; A M Conge; M Lassonnery; R Caravano; D Rieu; A Serre
Journal:  Presse Med       Date:  1991-11-02       Impact factor: 1.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.